Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses

Show other versions (1)

Primaquine (PQ) kills Plasmodium vivax hypnozoites but can cause severe hemolysis in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. We conducted two systematic reviews. The first used data from clinical trials to determine the variety of definitions and frequency of hematological...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Yilma, D, Groves, ES, Brito-Sousa, JD, Monteiro, WM, Chu, C, Thriemer, K, Commons, RJ, Lacerda, MVG, Price, RN, Douglas, NM
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	American Society of Tropical Medicine and Hygiene 2023

Eitemau Tebyg

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
gan: Yilma, D, et al.
Cyhoeddwyd: (2021)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
gan: Price, RN, et al.
Cyhoeddwyd: (2018)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
gan: John, G, et al.
Cyhoeddwyd: (2012)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
gan: Watson, JA, et al.
Cyhoeddwyd: (2022)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
gan: Watson, J, et al.
Cyhoeddwyd: (2018)

Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure
gan: Abla, N, et al.
Cyhoeddwyd: (2024)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
gan: Watson, JA, et al.
Cyhoeddwyd: (2024)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
gan: Taylor, WRJ, et al.
Cyhoeddwyd: (2023)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
gan: Taylor, WR, et al.
Cyhoeddwyd: (2021)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
gan: Rahmalia, A, et al.
Cyhoeddwyd: (2019)

Primaquine-induced severe hemolysis in the absence of concomitant malaria: effects on G6PD activity and renal function
gan: Douglas, NM, et al.
Cyhoeddwyd: (2022)

Primaquine for plasmodium vivax malaria treatment – authors' reply
gan: Price, RN, et al.
Cyhoeddwyd: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
gan: Setyadi, A, et al.
Cyhoeddwyd: (2019)

Progress towards safer and more effective radical cure of Plasmodium vivax
gan: Price, RN
Cyhoeddwyd: (2024)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
gan: Poespoprodjo, JR, et al.
Cyhoeddwyd: (2021)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
gan: Taylor, WRJ, et al.
Cyhoeddwyd: (2019)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
gan: Pukrittayakamee, S, et al.
Cyhoeddwyd: (2010)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
gan: Commons, RJ, et al.
Cyhoeddwyd: (2020)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
gan: Llanos-Cuentas, A, et al.
Cyhoeddwyd: (2019)

Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia.
gan: Fryauff, D, et al.
Cyhoeddwyd: (1997)

Evidence uptake is only part of the process: stakeholders’ insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria
gan: Ruwanpura, VSH, et al.
Cyhoeddwyd: (2024)

Improving the radical cure of Plasmodium vivax malaria.
gan: Price, R
Cyhoeddwyd: (2014)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
gan: Thriemer, K, et al.
Cyhoeddwyd: (2020)

Plasmodium vivax in the era of the shrinking P. falciparum map
gan: Price, RN, et al.
Cyhoeddwyd: (2020)

A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria
gan: Sadhewa, A, et al.
Cyhoeddwyd: (2023)

Strategies for improving radical cure in P. vivax malaria
gan: John, G
Cyhoeddwyd: (2012)

Declining burden of plasmodium vivax in a population in Northwestern Thailand from 1995 to 2016 before comprehensive primaquine prescription for radical cure
gan: Chu, CS, et al.
Cyhoeddwyd: (2019)

Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
gan: Ruwanpura, VSH, et al.
Cyhoeddwyd: (2021)

Primaquine induced haemolysis in G6PD heterozygous females treated for the radical cure of Plasmodium vivax malaria: a nested cohort study
gan: Chu, C, et al.
Cyhoeddwyd: (2017)

Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
gan: Abreha, T, et al.
Cyhoeddwyd: (2015)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
gan: Rahmalia, A, et al.
Cyhoeddwyd: (2023)

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
gan: Thriemer, K, et al.
Cyhoeddwyd: (2022)

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
gan: Fadilah, I, et al.
Cyhoeddwyd: (2024)

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
gan: Commons, RJ, et al.
Cyhoeddwyd: (2023)

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
gan: Mehdipour, P, et al.
Cyhoeddwyd: (2023)

Single-dose radical cure of Plasmodium vivax: a step closer.
gan: Price, R, et al.
Cyhoeddwyd: (2014)

Single-dose radical cure of Plasmodium vivax: A step closer
gan: Price, R, et al.
Cyhoeddwyd: (2014)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
gan: Rajasekhar, M, et al.
Cyhoeddwyd: (2023)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
gan: Poespoprodjo, Jeanne Rini, et al.
Cyhoeddwyd: (2022)

Challenges for achieving safe and effective radical cure of P. vivax – a round table discussion of the APMEN Vivax Working Group
gan: Thriemer, K, et al.
Cyhoeddwyd: (2017)